Approval for use of dual interfix-rp(tm) threaded fursion devices (instead of the already approved use of a single interfix-rp(tm) threaded fusion device used in conjunction with an interfix(tm) threaded fusion device)  the unmodified device will continue to be marketed under the trade name interfix-rp(tm) threaded fusion device and is indicated for spinal fusion procedures in skeletally mature patients wtih degenerative disc disease (ddd) at one level from l2-s1.  Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies.  These ddd patients may also have up to grade i spondylolisthesis or retrolisthesis at the involved level.  Interfix-rp(tm) threaded fusion devices are to be used with autogenous bone graft and implanted via an open anterior approach.  Patients receiving the interfix-rp(tm) threaded fusion devices should have had at least six months of nonoperative treatment prior to treatment with the interfix-rp(tm) threaded fusion device.